Cargando…

A Prescribing Cascade of Proton Pump Inhibitors Following Anticholinergic Medications in Older Adults With Dementia

Introduction: Prescribing cascade refers to use of a medication to treat a drug-related adverse event. Prescribing cascades increase medication use, cost, and risk of adverse events. Objective: Our objective was to use administrative health data to identify whether use of medications from the antich...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trenaman, Shanna C., Harding, Austin, Bowles, Susan K., Kirkland, Susan A., Andrew, Melissa K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257131/ https://www.ncbi.nlm.nih.gov/pubmed/35814221 http://dx.doi.org/10.3389/fphar.2022.878092

Ejemplares similares

An examination of three prescribing cascades in a cohort of older adults with dementia
por: Trenaman, Shanna C., et al.
Publicado: (2021)

Potentially Inappropriate Drug Duplication in a Cohort of Older Adults with Dementia
por: Trenaman, Shanna C., et al.
Publicado: (2021)

An investigation of psychoactive polypharmacy and related gender-differences in older adults with dementia: a retrospective cohort study
por: Trenaman, Shanna C, et al.
Publicado: (2023)

The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs
por: Trenaman, Shanna C., et al.
Publicado: (2021)

Evaluating physicians’ awareness and prescribing trends regarding proton pump inhibitors: a cross-sectional study
por: Swed, Sarya, et al.
Publicado: (2023)

Sex and gender differences in polypharmacy in persons with dementia: A scoping review
por: Trenaman, Shanna C, et al.
Publicado: (2019)

Case Report: The Complexities of Managing Medications and the Importance of Deprescribing Anticholinergics in Older Adults
por: Elliott, Taylor, et al.
Publicado: (2021)

Research on prescribing cascades: a scoping review
por: Chen, Zhe, et al.
Publicado: (2023)

High anticholinergic burden at admission associated with in‐hospital mortality in older patients: A comparison of 19 different anticholinergic burden scales
por: Lisibach, Angela, et al.
Publicado: (2021)

Proton Pump Inhibitors and Cancer: Current State of Play
por: Bridoux, Marie, et al.
Publicado: (2022)

Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study
por: Liu, Yujuan, et al.
Publicado: (2020)

The Prognostic Value of Anticholinergic Burden Measures in Relation to Mortality in Older Individuals: A Systematic Review and Meta-Analysis
por: Graves-Morris, Katherine, et al.
Publicado: (2020)

Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan
por: Liu, Yia-Ping, et al.
Publicado: (2020)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Proton Pump Inhibitors in IPF: A Call for Clinical Trials
por: Ghebre, Yohannes T.
Publicado: (2018)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia
por: Carter, Elizabeth, et al.
Publicado: (2020)

Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
por: Chueca, Eduardo, et al.
Publicado: (2016)

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
por: Dipasquale, Valeria, et al.
Publicado: (2022)

Proton-pump inhibitors should be strictly prescribed in clinic
por: Yang, Xuesong, et al.
Publicado: (2022)

Prescribing cascades in older adults
por: Sternberg, Shelley A., et al.
Publicado: (2021)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
por: Lazzerini, Pietro E., et al.
Publicado: (2018)

Proton pump inhibitors and dementia: what association?
por: Caetano, Catarina, et al.
Publicado: (2023)

Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review
por: Salahudeen, Mohammed S., et al.
Publicado: (2022)

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan
por: Cheng, Kao-Chi, et al.
Publicado: (2017)

Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics
por: Matuz, Mária, et al.
Publicado: (2020)

Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study
por: Wang, Yao-Tung, et al.
Publicado: (2020)

Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department
por: Chen, Qiying, et al.
Publicado: (2022)

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
por: Tian, Liang, et al.
Publicado: (2023)

Prescribing patterns and economic costs of proton pump inhibitors in Colombia
por: Machado-Alba, Jorge, et al.
Publicado: (2013)

An anticholinergic burden score for German prescribers: score development
por: Kiesel, Esther Katharina, et al.
Publicado: (2018)

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
por: Aubert, Carole E., et al.
Publicado: (2023)

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)

When does proton pump inhibitor treatment become long term? A scoping review
por: Haastrup, Peter Fentz, et al.
Publicado: (2021)

The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism
por: Gao, Nanyong, et al.
Publicado: (2022)

Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults
por: Poonawalla, Insiya B., et al.
Publicado: (2023)

Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
por: Cahir, Caitriona, et al.
Publicado: (2012)

Prescribing efficiency of proton pump inhibitors in China: influence and future directions
por: Zeng, Wenjie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0kgg8upeup5fa6pgo7p8c0g1pq